{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:42:34Z","timestamp":1792024954039,"version":"4.4.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100016017","name":"Duke-NUS Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human adenovirus type 4 (HAdV-E4) frequently causes epidemics among military and civilian populations. We conducted a systematic review of 144 peer-reviewed articles reporting HAdV-E4 infections, published during the years 1960\u20132020. More than 24 500 HAdV-E4 infections, including 27 associated deaths, were documented. HAdV-E4 infections were reported from all geographic regions of the world except Central America and the Caribbean. The number of publications reporting civilian infections tripled in the last decade, with a steady increase in reported civilian infections over time. Infections commonly caused respiratory and ocular disease. North America reported the most infections, followed by Asia and Europe. The majority of deaths were reported in the United States, followed by China and Singapore. Civilians seem to increasingly suffer HAdV-E4 disease, with recent epidemics among US college students. Public health officials should consider seeking emergency use authorization for the adenovirus vaccine such that it might be available to mitigate civilian epidemics.<\/jats:p>","DOI":"10.1093\/cid\/ciab146","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T20:28:26Z","timestamp":1613161706000},"page":"740-746","source":"Crossref","is-referenced-by-count":18,"title":["Six Decades of Human Adenovirus Type 4 Infections Reviewed: Increasing Infections Among Civilians Are a Matter of Concern"],"prefix":"10.1093","volume":"73","author":[{"given":"Kristen K","family":"Coleman","sequence":"first","affiliation":[{"name":"Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R","family":"Robie","sequence":"additional","affiliation":[{"name":"Duke Global Health Institute, Duke University, Durham, North Carolina, USA"},{"name":"Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-9972","authenticated-orcid":false,"given":"Anfal","family":"Abdelgadir","sequence":"additional","affiliation":[{"name":"Duke Global Health Institute, Duke University, Durham, North Carolina, USA"},{"name":"Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi S","family":"Kozhumam","sequence":"additional","affiliation":[{"name":"Duke Global Health Institute, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel A","family":"Binder","sequence":"additional","affiliation":[{"name":"Duke Global Health Institute, Duke University, Durham, North Carolina, USA"},{"name":"Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C","family":"Gray","sequence":"additional","affiliation":[{"name":"Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore"},{"name":"Duke Global Health Institute, Duke University, Durham, North Carolina, USA"},{"name":"Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA"},{"name":"Global Health Research Center, Duke Kunshan University, Kunshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"2021081616413732100_CIT0001","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3181\/00379727-85-20825","article-title":"Recovery of new agent from patients with acute respiratory illness","volume":"85","author":"Hilleman","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"key":"2021081616413732100_CIT0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2013.05.014","article-title":"Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events","volume":"443","author":"Dehghan","year":"2013","journal-title":"Virology"},{"key":"2021081616413732100_CIT0003","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/JVI.79.4.2559-2572.2005","article-title":"Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development","volume":"79","author":"Purkayastha","year":"2005","journal-title":"J Virol"},{"key":"2021081616413732100_CIT0004","first-page":"566","article-title":"Adenoviral infections in Singapore: should new antiviral therapies and vaccines be adopted?","volume":"221","author":"Coleman","year":"2019","journal-title":"J Infect Dis"},{"key":"2021081616413732100_CIT0005","doi-asserted-by":"crossref","first-page":"e0205795","DOI":"10.1371\/journal.pone.0209720","article-title":"Epidemiology, clinical presentation and respiratory sequelae of adenovirus pneumonia in children in Kuala Lumpur, Malaysia","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"2021081616413732100_CIT0006","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid2402.171407","article-title":"Adenovirus type 4 respiratory infections among civilian adults, Northeastern United States, 2011\u20132015","volume":"24","author":"Kajon","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2021081616413732100_CIT0007","first-page":"177","article-title":"Molecular characterization of human adenoviruses isolated in Italy","volume":"29","author":"La Rosa","year":"2006","journal-title":"New Microbiol"},{"key":"2021081616413732100_CIT0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/v11020129","article-title":"A survey of recent adenoviral respiratory pathogens in Hong Kong reveals emergent and recombinant human adenovirus type 4 (HAdV-E4) circulating in civilian populations","volume":"11","author":"Zhang","year":"2019","journal-title":"Viruses"},{"key":"2021081616413732100_CIT0009","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7883\/yoken.JJID.2015.414","article-title":"Detection and molecular typing of human adenovirus associated with respiratory illness in Kerala","volume":"69","author":"Thounaojam","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"2021081616413732100_CIT0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijid.2018.08.009","article-title":"A swimming pool-associated outbreak of pharyngoconjunctival fever caused by human adenovirus type 4 in Beijing, China","volume":"75","author":"Li","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2021081616413732100_CIT0011","article-title":"Outbreaks of adenovirus-associated respiratory illness on five college campuses in the United States","author":"Kujawski","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021081616413732100_CIT0012","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","article-title":"Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999\u20132004","volume":"24","author":"Russell","year":"2006","journal-title":"Vaccine"},{"key":"2021081616413732100_CIT0013","doi-asserted-by":"crossref","first-page":"e1765","DOI":"10.7205\/MILMED-D-16-00308","article-title":"Adenovirus-associated acute appendicitis: an under-recognized relationship?","volume":"182","author":"Lynch","year":"2017","journal-title":"Mil Med"},{"key":"2021081616413732100_CIT0014","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-3-642-81553-9_104","article-title":"Diffuse meningocerebral angiodysplasia and adenovirus infection: an improbable relationship","volume":"7","author":"Flament-Durand","year":"1981","journal-title":"Acta Neuropathol Suppl"},{"key":"2021081616413732100_CIT0015","first-page":"553","article-title":"Two fatal cases of adenovirus-related illness in previously healthy young adults--Illinois, 2000","volume":"50","author":"Ryan","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021081616413732100_CIT0016","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciu507","article-title":"Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines","volume":"59","author":"Radin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021081616413732100_CIT0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/518442","article-title":"Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997\u20132003)","volume":"196","author":"Kajon","year":"2007","journal-title":"J Infect Dis"},{"key":"2021081616413732100_CIT0018","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/313999","article-title":"Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group","volume":"31","author":"Gray","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2021081616413732100_CIT0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-323-35761-6.00010-9","article-title":"Adenovirus vaccines","volume-title":"Plotkin\u2019s Vaccines","author":"Gray","year":"2018"},{"key":"2021081616413732100_CIT0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3201\/eid1803.111238","article-title":"Adenovirus-associated deaths in US military during postvaccination period, 1999\u20132010","volume":"18","author":"Potter","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2021081616413732100_CIT0021","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bjo.66.12.776","article-title":"Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections","volume":"66","author":"Aoki","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"2021081616413732100_CIT0022","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jmv.21175","article-title":"Monitoring of adenovirus from conjunctival scrapings in Japan during 2005\u20132006","volume":"80","author":"Matsui","year":"2008","journal-title":"J Med Virol"},{"key":"2021081616413732100_CIT0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004397-200201000-00008","article-title":"A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan","volume":"42","author":"Aoki","year":"2002","journal-title":"Int Ophthalmol Clin"},{"key":"2021081616413732100_CIT0024","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1128\/JCM.38.11.4114-4120.2000","article-title":"Species-specific identification of human adenoviruses by a multiplex PCR assay","volume":"38","author":"Xu","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2021081616413732100_CIT0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcv.2004.04.003","article-title":"Development of a PCR-and hybridization-based assay (PCR Adenovirus Consensus) for the detection and the species identification of adenoviruses in respiratory specimens","volume":"31","author":"Vabret","year":"2004","journal-title":"J Clin Virol"},{"key":"2021081616413732100_CIT0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00705-006-0842-8","article-title":"Detection and sequence-based typing of human adenoviruses using sensitive universal primer sets for the hexon gene","volume":"152","author":"Okada","year":"2007","journal-title":"Arch Virol"},{"key":"2021081616413732100_CIT0027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcv.2009.06.008","article-title":"Molecular typing of clinical adenovirus specimens by an algorithm which permits detection of adenovirus coinfections and intermediate adenovirus strains","volume":"46","author":"McCarthy","year":"2009","journal-title":"J Clin Virol"},{"key":"2021081616413732100_CIT0028","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jcv.2010.01.005","article-title":"Human adenoviruses in respiratory infections: sequencing of the hexon hypervariable region reveals high sequence variability","volume":"47","author":"Biere","year":"2010","journal-title":"J Clin Virol"},{"key":"2021081616413732100_CIT0029","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/JVI.00491-11","article-title":"Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology","volume":"85","author":"Aoki","year":"2011","journal-title":"J Virol"},{"key":"2021081616413732100_CIT0030","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/JVI.00354-11","article-title":"Using the whole-genome sequence to characterize and name human adenoviruses","volume":"85","author":"Seto","year":"2011","journal-title":"J Virol"},{"key":"2021081616413732100_CIT0031","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.15585\/mmwr.mm6639a2","article-title":"Human adenovirus surveillance\u2014United States, 2003\u20132016","volume":"66","author":"Binder","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021081616413732100_CIT0032","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2019.08.028","article-title":"Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor","volume":"538","author":"Gonzalez","year":"2019","journal-title":"Virology"},{"key":"2021081616413732100_CIT0033","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/milmed\/160.6.300","article-title":"Adenovirus vaccines in the U.S. military","volume":"160","author":"Gaydos","year":"1995","journal-title":"Mil Med"},{"key":"2021081616413732100_CIT0034","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"key":"2021081616413732100_CIT0035","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.vaccine.2013.04.035","article-title":"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits","volume":"31","author":"Kuschner","year":"2013","journal-title":"Vaccine"},{"key":"2021081616413732100_CIT0036","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1016\/j.vaccine.2019.08.087","article-title":"Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the vaccine adverse event reporting system (VAERS), United States, October 2011\u2013July 2018","volume":"37","author":"McNeil","year":"2019","journal-title":"Vaccine"},{"key":"2021081616413732100_CIT0037","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/vaccines8030411","article-title":"Live oral adenovirus type 4 and type 7 vaccine induces durable antibody response","volume":"8","author":"Collins","year":"2020","journal-title":"Vaccines"},{"key":"2021081616413732100_CIT0038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3201\/eid2301.161297","article-title":"Acute respiratory disease in US army trainees 3 years after reintroduction of adenovirus vaccine 1","volume":"23","author":"Clemmons","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2021081616413732100_CIT0039","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab146\/36787216\/ciab146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/4\/740\/39763941\/ciab146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/4\/740\/39763941\/ciab146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T17:06:31Z","timestamp":1629133591000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/4\/740\/6157989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,10]]},"published-print":{"date-parts":[[2021,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab146","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,15]]},"published":{"date-parts":[[2021,3,10]]}}}